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a b s t r a c t
Population growth particularly in countries with developing economies will result in a need to increase
food production by 70% by the year 2050. Biotechnology has been utilized to produce genetically modiﬁed
(GM) crops for insect and weed control with beneﬁts including increased crop yield and will also be used
in emerging countries. A multicomponent safety assessment paradigm has been applied to individual GM
crops to determine whether they as safe as foods from non-GM crops. This paper reviews methods to
assess the safety of foods from GM crops for safe consumption from the ﬁrst generation of GM crops. The
methods can readily be applied to new products developed within country and this paper will emphasize
the concept of data portability; that safety data produced in one geographic location is suitable for safety
assessment regardless of where it is utilized.
© 2015 The Authors. Published by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Environmental factors including damage from insects and com-
etition with weeds for resources necessary to support growth
ontribute to decreased yield from ﬁeld crops. Historically, syn-
hetic insecticides have been used for protection of plants from
nsect damage and herbicides have been used to control weeds.
hile they have been effective, more recent developments have
pplied the tools of biotechnology to produce genetically mod-
ﬁed (GM) crops for insect and weed control. Early generation
M crops including insect resistant maize and herbicide tolerant
oybeans express proteins from foreign sources that endow them
ith these particular phenotypes. They have been cultivated in the
nited States for nearly 20 years with signiﬁcant beneﬁts includ-
ng decreased use of pesticides and herbicides, yield increases, de-
reased labor costs and improvements in quality (Brookes and Bar-
oot, 2009; Klümper and Qaim, 2014).
During the course of developing early generation GM ﬁeld crops
multicomponent safety assessment paradigm was also developed
ased on recommendations and guidelines from scientiﬁc and reg-
latory authorities that is referred to as substantial equivalence
World Health Organization (WHO, 1991). The goal of the safety as-
essment for foods from GM crops was to produce laboratory data
or individual GM crops to demonstrate that they were as safe as
oods from non-GM crops. This paradigm and the ensuing meth-
ds to demonstrate substantial equivalence has proven quite effec-
ive as foods from GM crops have a well-established history of safe
onsumption in the US and in other countries that have imported
oods from GM crops and cultivated GM crops.
It has been estimated that food production will need to in-
rease by 70% by the year 2050 based on population growth par-
icularly in countries with developing economies (Food and Agri-
ulture Organization of the United Nations (FAO, 2009)). The num-
er of countries and the populations within them far exceed those
ountries with more advanced economies as they include China,
ndia, and other populous Asian and African countries.
Countries with developing economies stand to beneﬁt from
iotechnology for the same reasons as countries with more ad-
anced economies. Whether imported or cultivated from other
ountries or developed independently, foods from GM crops should
e as safe as those from non-GM plants regardless of where they
riginate. This chapter reviews methods established to assess the
afety of foods from GM crops for safe consumption in early gen-
ration products. Insect resistance and herbicide tolerance are em-
hasized for two reasons. First, there is a tremendous amount of
xperience with variants of GM crops with these two phenotypes.
he methods used to assess the safety of these early generation
M crops are relevant for safety assessment of any type of GM
lant – not just soybeans and maize. Second, both the insect resis-
ance and herbicide tolerance phenotypes will be used regardless
f geography even if the range of plants to be transformed with
hem is more diverse than common US ﬁeld crops such as soy-
eans and corn.
Understanding the methods of safety assessment will beneﬁt
rop developers, regulators and other scientists as it will be shown
hat they not only demonstrate the safety of currently available GM
roducts but that the methods can readily be applied to newly de-
eloped GM crops as well.
.1. Agricultural biotechnology
Biotechnology is a process whereby speciﬁc genes are trans-
erred from one species into another. This introduction of foreign
NA is typically via engineered plasmids (i.e., vectors) or by phys-
cal processes such as particle bombardment that deliver the DNA
o the nucleus of the recipient plant. In many cases these genesxpress proteins that endow the plant with a targeted pheno-
ype or trait by design. The most commonly expressed proteins
n GM crops are those with herbicide tolerance and insect resis-
ance activities though other GM crops products express proteins
hat express disease resistance, stress tolerance or other pheno-
ypes (http://www.isaaa.org/). It should also be noted that not all
M crops express proteins as some modiﬁcations are attributable
o gene regulation by RNA (Petrick et al., 2013). Regardless of the
ntent, the introduced gene or genes become permanently incorpo-
ated into the genome of the recipient. The process of biotechnol-
gy permits the transfer of genes across species so that compati-
ility between the source and the recipient of any particular gene
s not a limiting factor in transfer as it typically is using traditional
reeding methods.
Within approximately the last 20 years, biotechnology has been
pplied to agriculture with a focus on two factors that signiﬁcantly
mpact yield; damage from insects and competition with weeds.
arlier generation GM crops express traits that increase yield, im-
rove quality and reduce the costs of production as these bene-
ts have long been sought by traditional breeders as well (Organi-
ation for Economic Co-operation and Development OECD, 1993).
t is also not surprising that these traits were targeted since they
ere developed by seed companies.
Insect resistant and herbicide tolerant phenotypes have been
roduced in numerous ﬁeld crops from the transfer of genes that
xpress proteins with insecticidal or herbicide tolerance activities,
espectively. Extensive research has and will continue to focus on
dentiﬁcation and characterization of proteins that are capable of
mparting these types of traits. It should also be noted that GM
rops have also been developed using proteins with other biolog-
cal activities and with RNAi technology to silence speciﬁc genes
ather than introduce new ones. For information related to the
ethods of safety assessment for these technologies the reader is
eferred elsewhere (Parrott et al., 2010; Petrick et al., 2013; Bushey
t al., 2014).
.1.1. Insect resistance
Every year, insects cause damage to ﬁeld crops that result in
oss of yield. In the case of maize, Lepidoptera species including
he European corn borer (Ostrinia nubilalis) and corn earworm (He-
icoverpa zea) and Coleopteran species such as the corn rootworm
Diabrotica virgifera virgifera) are particularly damaging predatory
nsects owing to the feeding patterns of the larvae from these
pecies.
Synthetic insecticides including organophosphates, pyrethroids,
nd carbamates have been used to control damage from these and
ther types of insects. In organic farming where pesticide use is
uch more restricted, the soil bacteria Bacillus thuringiensis (Bt)
as been used as an insecticide for more than 50 years (United
tates Environmental Protection Agency US-EPA, 1998a, b). The in-
ecticidal activity of certain strains of Bt bacteria is attributable
o the expression of crystalline (Cry) proteins that form pores in
he uniquely alkaline gut of the sensitive insects when consumed
Chambers et al., 1991; Kullik et al., 2011; Schnepf et al., 1998;
an et al., 2011). Insects including the lepidopteran and coleopteran
pecies cited above also express receptors that speciﬁcally bind the
t proteins which greatly restricts their selectivity (Pigott and Ellar,
007).
Biotechnology has been used to produce insect resistant maize
lants by transforming plants to express Cry proteins from differ-
nt strains of Bt bacteria. To date, many different varieties of GM
aize and other crops have been commercialized that express dif-
erent Cry proteins from different strains of Bt bacteria and they
ave been successful in controlling numerous yield damaging in-
ects (http://www.isaaa.org). During the course of developing these























































sproducts much has been learned about the safety of insecticidal
proteins that will be discussed in subsequent sections of this chap-
ter.
1.1.2. Herbicide tolerance
Another early generation GM crop that will be discussed in
this chapter is herbicide tolerant crops (Barry et al., 1992). As an
example, consider glyphosate tolerant soybeans. All plants, bacte-
ria, and fungi express 5-enolpyruvyl-shikimate-3-phosphate syn-
thase (EPSPS), an enzyme that is critical for biosynthesis of aro-
matic amino acids (Padgette et al., 1991, 1996). The native form
of this enzyme expressed in ﬁeld crops is sensitive to inhibition
by glyphosate so that phytotoxicity results following in planta ap-
plication of glyphosate. However, the EPSPS variant expressed in
Agrobacterium tumefaciens strain CP4 is not sensitive to inhibi-
tion from glyphosate (Padgette et al., 1995; Funke et al., 2006).
Glyphosate tolerant soybeans were produced using biotechnology
to express the CP4 variant of the EPSPS enzyme and therefore tol-
erate application of glyphosate.
Numerous other proteins have been used to confer tolerance to
other herbicides including dicamba, 2,4-D, sulfonylurea, and glu-
fosinate in variety of different ﬁeld crops and all of them are
attributable to expression of an exogenous protein (http://www.
isaaa.org).
2. Early safety assessment guidelines and recommendations
Crops produced with biotechnology have been referred to as ge-
netically modiﬁed or GM crops. Correspondingly, the whole foods
and edible fractions from these plants are often considered “GM
foods” but it is more accurate to refer to them as foods obtained
from GM crops. Perhaps because the methods by which they have
been produced differ from traditional breeding or possibly because
the genes responsible for the imparted traits came from sources
unrelated to the crop in which they are expressed, there were
questions about whether foods obtained from them were safe to
eat.
Among the ﬁrst organizations to propose strategies to assess
the safety of foods obtained from biotechnology was that of WHO
(1991). The document this group authored noted that the appli-
cation of biotechnology to food production is really not particu-
larly novel as it can be traced to more than 8000 years ago so
that the technology itself is not inherently hazardous. Shortly af-
ter the publication of these recommendations, other scientiﬁc and
regulatory agencies published similar documents that rather than
speciﬁcally indicating which tests or what types of data should be
considered, these recommendations did allow for ﬂexibility with
regard to data requirements in the safety assessment of individual
GM crops (Codex Alimentarius Commission [Codex], 2001, 2003a,
2003b, 2007; European Commission [EC], 1997, 2003a, 2003b,
2004; European Food Safety Authority EFSA, 2006a, 2006b; FAO,
1996; FAO/WHO, 2000; International Life Sciences Institute ILSI,
1996, 1997, 2003, 2004; OECD, 1993, 1997, 2003; WHO, 1995).
Recognizing that most of the early generation GM crops were
developed to express proteins, these documents highlighted that
proteins are an integral component of the diet. As a general class
of dietary ingredients, proteins do not present an obvious risk to
humans since they are readily digested into amino acids that are
absorbed for nutritive purposes. They did, however, acknowledge
that there are some proteins that exist in nature that can present
hazard in the form of potential for allergenicity or toxicity. Accord-
ingly, a weight of evidence approach was developed based on what
was known about allergenic and toxic proteins to compare candi-
date proteins with known allergenic and toxic proteins before com-
mercialization.In addition to testing the proteins to be expressed in GM crops,
he strategy discussed in the documents cited above with regard to
afety testing of whole foods obtained from them was that of “sub-
tantial equivalence.” The central tenet of this concept was the def-
nition of food safety as “based on the concept that there should be
reasonable certainty that no harm will result from intended uses
nder the anticipated conditions of consumption (OECD, 1993).”
The concept of substantial equivalence refers primarily to the
omposition of the newly developed GM crop in relation to the
omposition of non-GM crops. Because GM crops have been de-
eloped speciﬁcally to have a particular phenotype that otherwise
ould not be present in the non-GM crop they cannot be expected
o be absolutely equivalent. Rather, that compositional data is nec-
ssary to demonstrate that the process of transformation did not
esult in the introduction of unintended changes that could result
n a product that was not safe. The OECD stated “If a new food or
ood component is found to be substantially equivalent to an exist-
ng food or food component, it can be treated in the same manner
ith respect to safety. No additional safety concerns would be ex-
ected (OECD, 1993).” This prescient concept remains the basis of
afety assessment of foods from GM crops today.
While the documents cited above highlighted concepts, they did
ot mandate speciﬁc studies or data that would be absolutely re-
uired in every instance for newly developed GM crops. Never-
heless, a data driven paradigm has been developed to assess the
afety of foods from GM crops. Details about the individual com-
onents in these types of assessments is discussed below but what
hould be noted here with particular regard to countries with de-
eloping economies is that the methods used to assess the safety
f proteins expressed in GM crops and in foods obtained from
hem are well established and new methods should not be re-
uired. Some of the individual steps require very little with regard
o resources and training whereas others can be particularly re-
ource intensive.
. Safety assessment of proteins used in GM crops
Candidate proteins to be expressed in GM crops are compared
nd contrasted with proteins that are allergenic or toxic using a
eight of evidence approach consisting of individual and indepen-
ent studies. None of the individual studies or data are necessarily
ore or less important than the others when considered in the
ontext of weight of evidence but typically numerous studies are
onducted.
.1. Allergenicity
In the US, it has been estimated that 6–8% of children and 1–
% of adults are allergic to one or more foods (Sampson and Met-
alfe, 1992; Metcalfe et al., 1996). The percentage decreases with
ge as many people outgrow the allergy. The incidence of food al-
ergy outside of the US is unknown. Based on the US population, it
s also known that the majority of food allergies are attributable to
relatively small number of foods that include peanuts, soybeans,
ow’s milk, eggs, ﬁsh, shellﬁsh, wheat and tree nuts. Many other
oods have also been reported to cause allergic reactions though
he frequency of these sensitivities is much lower (Heﬂe et al.,
996). Persons that are allergic to particular foods possess antibod-
es to certain proteins present within those foods and the primary
ethod of treating food allergies is for the allergic person to sim-
ly avoid consuming them.
Much is known about the particular proteins in foods to which
ersons are sensitive and they are often referred to as allergenic
roteins. This is not necessarily a technically accurate appellation
ince it implies that these proteins present some risk of allergic






















































































































geactions in anyone when in fact they only present a risk in per-
ons that are sensitive to them. Nevertheless, key learnings about
hese proteins have been applied to the safety assessment of foods
rom GM crops. In particular, safety assessments are designed to
nsure that the developer did not select a protein to which a sen-
itive person could be exposed to unknowingly. Potential for aller-
enicity is assessed for proteins to ensure that they are not similar
nough to cross react with the antibodies present in persons with
ood allergies.
One well documented example illustrating the potential to un-
ntentionally transfer an allergenic protein is the case where a GM
oybean was transformed to express a protein obtained from Brazil
uts to increase the concentration of the amino acid methionine.
he protein that was selected, 2S albumin, happened to be the pri-
ary allergenic protein in persons allergic to Brazil nuts (Nordlee
t al., 1996). Development of this product was halted before com-
ercialization and it never went to market. If it had, persons that
ere allergic to Brazil nuts could have been unintentionally and
nknowingly exposed to this protein upon consumption of GM
oybeans in which this protein was expressed. Since it was never
ommercialized no allergic reactions ever occurred.
The source of the proteins is an important criterion in selec-
ion of candidate proteins. This is one component of the safety as-
essment for individual proteins called History of Safe Use (HOSU;
onstable et al., 2007). However, each situation needs to be con-
idered on a case-by-case basis. For example, peanuts may not be
he best source for proteins to be used in GM crops like maize
r soybeans simply because peanuts are known to possess more
han one allergenic protein (De Jong et al., 1998). Regardless of
he identity of the individual protein there would likely be con-
erns that any protein from peanuts could possibly be allergenic.
lternatively, if a protein from peanuts were to be selected to be
xpressed in a GM peanut plant then no new hazard has been in-
roduced with regard to potential allergenicity.
In the case of Cry proteins from different strains of Bt bacteria
r EPSPS from Agrobacterium strain CP4, the source organisms sim-
ly do not produce proteins that are known to be allergenic in hu-
ans. Therefore, GM crops expressing proteins from these sources
o not present an obvious risk for introduction of an allergenic or
oxic protein. These examples illustrate the concept that the sourc-
ng of proteins from non-allergenic sources is prudent.
Another key component in the allergenicity assessment is a
ioinformatics comparison of the amino acid sequence of the pro-
ein with the sequences of known allergenic proteins for similar-
ty using computational methods. The identity and amino acid se-
uence of all known allergenic proteins is available on line and up-
ated annually (www.allergenonline.org). While this database does
ot contain every allergenic protein in existence it does contain ev-
ry known allergenic protein. Importantly, of the millions or greater
umber of proteins that exist in nature, only 1706 were actually
onsidered allergens as of the latest update (January 20, 2014).
The Codex Alimentarius Commission reported that proteins in
M crops could present a risk for cross reactivity if they have 35%
mino acid sequence identity over any 80 amino acid sequence or
ny identical 8 amino acid matches with known allergens (Codex,
003a, b, c). More recent data has demonstrated that the latter cri-
erion is prone toward giving false positives (Ladics et al., 2011).
hat it important for countries with developing economies is that
his database and the bioinformatics software programs necessary
o make these types of comparison (e.g., FASTA) are freely available
nline.
A physical property shared by numerous, but not all, aller-
enic proteins is resistance to degradation in the presence of di-
estive enzymes (Astwood et al., 1996). Standardized in vitro meth-
ds have been developed to evaluate the sensitivity of proteins to
egradation in the presence of digestive enzymes (pepsin and pan-reatin; Thomas et al., 2004). Numerous publications have reported
hat insecticidal and herbicide tolerance proteins are rapidly de-
raded in the presence of digestive enzymes (Harrison et al., 1996;
rivalle, 2002; Herman et al., 2003; Sinagawa-Garcia et al., 2004;
erouet et al., 2005; Hileman et al., 2006; Singh et al., 2006; De-
aney et al., 2008a, b; Hérouet-Guicheney et al., 2009; Mathesius
t al., 2009; Xu et al., 2009; Cao et al., 2010, 2012). This property
s not absolute as some non-allergenic proteins are also insensi-
ive to degradation by digestive enzymes. Nevertheless, this data is
nother component of the overall weight of evidence in the assess-
ent of whether proteins to be used in GM crops are likely to be
llergenic.
These methods have been very effective at identifying poten-
ially allergenic proteins, however, if questions still remain follow-
ng these analyses further studies can be considered. For example,
f bioinformatics results suggest marginal sequence similarities be-
ween the protein to be expressed in GM crops and a known aller-
en, serum obtained from individuals sensitive to that protein can
e used to determine whether cross reactivity is possible. Results
rom these types of studies have not revealed evidence of cross
eactivity though they are not commonly conducted (Ladics et al.,
006). It has also been suggested that clinical trials in sensitive
ndividuals could be conducted though to date none have been re-
orted.
Collectively, these studies have successfully demonstrated that
he methods used to assess the allergenicity of proteins expressed
n GM crops are effective. Nearly 20 years following commercial-
zation of the ﬁrst GM crop there have been no reports of allergic
eactions that are attributable to exposure to foods obtained from
hem.
.2. Toxicity
In addition to allergenicity, some proteins are known to exist in
ature that are capable of causing adverse effects when consumed.
hough many are found in venomous snakes and insects or are
roduced by pathogenic bacteria, there are some that are found
n plants such as kidney bean lectin and ricin (Rossi et al., 1984;
afont et al., 1988; Weinman et al., 1989; Ishiguro et al., 1992a and
992b; Cook et al., 2006). Accordingly, proteins used in GM crops
ave also been assessed for potential to cause adverse effects if for
o other reason that they too are proteins.
There are obvious overlaps in the methods used to assess the
otential toxicity and allergenicity of proteins. Speciﬁcally, consid-
ration of history of safe use of the source of the protein, bioinfor-
atics comparison to known protein toxins, and in vitro resistance
o digestive enzymes (Delaney et al., 2007). The primary basis of
hese considerations being that proteins selected from sources that
re not known to produce toxic proteins, are not similar in se-
uence to known protein toxins, and are readily degraded in the
resence of digestive enzymes are unlikely to be toxins.
There are differences in the bioinformatics analysis compared
ith the allergenicity assessment to note. First, there are no pre-
eﬁned criteria that identify a “match” between two proteins such
s the 35% identity over 80 amino acid sequences for allergenic
roteins. Second, there is currently no annotated and updated
atabase in which the sequence of protein toxins is maintained.
ather, what is commonly conducted is a comparison to all known
rotein sequences in the NCBI BLAST database (http://blast.ncbi.
lm.nih.gov/Blast.cgi) followed by manual inspection to determine
f sequence similarities are present. Consideration of these data
rovides strong evidence for whether the protein intended for use
n a GM crop is likely to introduce a hazard.
In numerous cases, acute toxicology studies have been con-
ucted in laboratory mice using proteins isolated from heterolo-
ous expression systems. The acute toxicology study is conducted

























































bbecause proteins that are toxic are believed to act through acute
mechanisms of action (Sjoblad et al., 1992). Some acute toxicol-
ogy studies have applied the OECD limit oral dose of 2000 mg/kg
of body weight while others have used other doses that are or-
ders of magnitude in excess of possible human exposure (Delaney
et al., 2008b; Mathesius et al., 2009). When compared with the
concentrations at which they are expressed in planta it is possible
to dose with much smaller quantities of protein but still be well
in excess of margins of possible exposure that would normally be
used for this component of the risk assessment. For that reason,
more recent studies have been conducted by estimating the di-
etary exposure to the proteins from the edible part of the GM crop
and dosing at approximately 1000× higher amounts which again
has demonstrated that very high doses of these proteins does not
result in adverse effects (Juberg et al., 2009; Stagg et al., 2012).
This approach can substantially decrease the quantity of protein re-
quired for conducting these types of studies which is particularly
important for intractable proteins – proteins with physical proper-
ties that will not allow them to be isolated in the quantities nec-
essary to conduct these studies (Bushey et al., 2014). None of the
studies has demonstrated evidence of adverse effects regardless of
dosing regimen and, collectively, these studies have been effective
in establishing the safety of individual proteins expressed in GM
crops.
Though regulatory testing requirements are not the focus of
this chapter, it should be noted that one regulatory agency (Eu-
ropean Food Safety Authority) does require a 28 day rodent tox-
icology study conducted in accordance with OECD 407 guidelines
with puriﬁed protein (OECD, 1995). The guidelines allow for ﬂexi-
bility with regard to administration of the test substance with re-
gard to whether the test substance is administered in the diet or
by oral gavage and at which doses it is to be administered. As
with the acute toxicology study, the OECD has established a limit
dose for repeated dose toxicology studies which is 1000 mg/kg
of body weight per day. They also provide details related to the
conduct of these types of studies that include the number of an-
imals (minimum of 5/sex/dose), housing conditions, and variables
to be monitored. As would be expected, the variables include pri-
mary indicators of health such as body weights, food consumption,
clinical chemistry, hematology and organ weights and histopathol-
ogy. The guidelines are written for conducting the studies in ro-
dents which leaves open the option of the study sponsor as to
whether the studies are to be conducted in rats or mice. In most
cases, the studies have been conducted with mice because they re-
quire smaller quantities of the test substance than if they were to
be conducted with rats. A number of repeated dose studies have
been conducted with herbicide tolerance and Cry proteins but to
date there has been no evidence of adverse effects (Delaney et al.,
2008a, b; Juberg et al., 2009; Mathesius et al., 2009; Stagg et al.,
2012). These observations support that the previous data (HOSU,
MOA, digestibility, and even acute toxicology) were predictive of
the outcome in the repeated dose study and therefore brings into
question whether they are necessary for every protein to be con-
sidered in a GM plant.
4. Safety assessment of whole foods from GM crops
The testing paradigm in the safety assessment of the foods from
GM crops can be considered in two different overall objectives. The
ﬁrst objective is to assess the safety of the intended change which
for purposes of this chapter, has been imparted by the expression
a protein as discussed above. The second objective is to determine
if transformation of the plant to express the protein(s) results in
unintended changes. Early recommendations and guidelines con-
cluded that it is not possible to demonstrate that any food is abso-
lutely safe but that there are many foods with a long history of safeonsumption (WHO, 1991). The standard for safety of foods from
M crops is therefore to determine whether they are substantially
quivalent with foods obtained from closely related non-GM crops.
he foods from GM crops should be essentially identical with the
ame food from a non-GM crop with the obvious exception of the
rotein and its intended effect on phenotype.
Characterization of the insertion using molecular biology has
een conducted for individual GM events. This is done to conﬁrm
he integrity of the DNA insert and copy number, that the insert
id not disrupt any genes or create new open reading frames, and
hat no backbone DNA was inserted (Codex, 2003b). These ele-
ents relate to the safety of the product because unintended ef-
ects could occur from transformation.
.1. Composition analysis
An important component of the data produced in the compar-
tive safety assessment is a detailed compositional analysis of the
ey nutrients, antinutrients, secondary metabolites and toxins of a
M crop and a non-GM comparator (WHO, 1991; OECD, 1993; ILSI,
996). Typically, these are conducted with whole foods from con-
rolled ﬁeld trials in which the GM crop, its closely related non-
M control (i.e., near isoline), and several unrelated commercially
vailable non-GM varieties are grown together. For more informa-
ion about the design and conduct of these ﬁeld trials the reader
s encouraged to look elsewhere as that topic falls outside of the
cope of this chapter (Paoletti and Germini, 2012).
While some foods are manufactured using “pure” ingredients
uch as sugar and salt that can easily be viewed as chemicals,
oods from GM crops are also a combination of individual chem-
cals. As such, whole foods from ﬁeld crops can be analyzed chem-
cally to determine their chemical composition. In the case of
aize, soybeans, canola, rice and cotton, the concentrations of the
omponents are available at a publicly available web site that is
anaged by the International Life Sciences Institute (https://www.
ropcomposition.org/query/index.html). This information is partic-
larly valuable in these types of comparison trials because simply
omparing any individual component of GM and a non-GM crop
ould identify statistical differences that are not biologically rele-
ant. Information about the range of concentrations for the indi-
idual components in non-GM crops is particularly important in
ssessing their concentrations as there would be expected to be
ome statistical differences between GM and non-GM crops since
o many different components are measured.
To date, many compositional studies have been conducted with
hole grains, seed, forage and in some cased processed fractions
rom insect resistant and herbicide tolerant GM maize and GM soy-
ean plants and no unintentional compositional changes have been
bserved (For example see Padgette et al., 1996; Ridley et al., 2002,
011; George et al., 2004; Herman et al., 2004, 2007; Obert et al.,
004; McCann et al., 2005, 2007; Oberdoerfer et al., 2005; Harri-
an et al., 2007a, 2007b, 2009, 2010; Drury et al., 2008; Lundry
t al., 2008, 2013; Berman et al., 2009, 2010, 2011; Zhou et al.,
011; Venkatesh et al., 2014). This indicates that the process of
ransformation and expression of proteins in GM crops does not
resent a clear risk in unintended compositional changes and sup-
orts that they are substantially equivalent to their non-GM com-
arators with a history of safe use.
.2. Feeding studies
When the compositional analysis between foods from GM and
on-GM crops is equivalent, there is not an obvious scientiﬁc
eason to conduct animal feeding trials as stated in a number
f guidelines and recommendations. However, “If the assessment
ased on molecular, biological, and chemical data does not allow























































































































fn informed judgment on safety, conventional assessment proce-
ures based on animal studies will be needed (WHO, 1991).” Toxi-
ology studies are not recommended in a check the box approach
ut rather on a case-by-case basis based on the ﬁndings from the
ompositional analysis (ILSI, 1996).
There are elements attributable to the food portion of crops
hat cannot be assessed by compositional analysis (i.e., palatabil-
ty). Perhaps also because of the “newness” of the methods that
ere used to produce the early generation GM crops, a number
f feeding studies have been conducted in support of their safety.
t has been acknowledged that toxicologic assessments of whole
oods is diﬃcult using traditional laboratory toxicology methods
WHO, 1991). Nevertheless, laboratory methods have been adapted
o assess the safety of foods from GM crops using a comparative
pproach.
One often conducted safety study with foods from GM crops is
he 90 day feeding study in laboratory rats. In most cases, labo-
atory toxicology studies have been conducted in accordance with
ECD 408 Guidelines (OECD, 1998). Historically, 90 day toxicology
tudies have been conducted with pure chemicals that were ad-
inistered at low, middle, and high doses. Over the course of the
n-life phase of the study, body weights and feed consumption and
ehavioral and clinical observations are measured at regular inter-
als. At the end of the study, a comprehensive battery of variables
ncluding clinical chemistry, hematology and coagulation, urinal-
sis, organ weights and histopathology are evaluated in order to
etermine the highest dose that the animals could tolerate with-
ut evidence of adverse effect (i.e., the No Observed Adverse Effect
evel [NOAEL]).
One design element that is often included in 90 day rat feed-
ng studies with whole foods from GM crops is the multiple ref-
rence groups that are fed diets containing similar concentrations
f either the whole grain or processed feed fraction obtained from
nrelated, commercially available, non-GM plants. Because the pri-
ary statistical comparison in these studies is between the GM
nd the non-GM group and because there are large number of
omparisons it is expected that statistical difference between these
wo groups will occur. Data obtained from the reference groups
as been useful in instances such as this to establish within study
anges for the individual variables to determine whether they were
reatment related and biologically relevant. As an example, in one
ecent 90 day feeding study, a lower serum sodium concentration
as observed in female rats consuming grain from an insect resis-
ant GM maize plant compared with rats consuming maize grain
rom the control non-GM group (Appenzeller et al., 2009a). While
he difference was slight in magnitude it was statistically signif-
cant. In this case the serum concentrations of sodium from the
eference groups was helpful in establishing that the values from
he GM group were within the range of control values from within
his study.
Using another example, the concentration of serum alkaline
hosphatase (ALKP) was lower in male rats consuming diets con-
aining grain from and insect resistant crop relative to rats con-
uming maize grain from the near isogenic control crop. Though
ower ALKP concentrations are not typically considered an adverse
ffect, the inclusion of reference groups was helpful in determin-
ng that the values observed in the 1507 group were well within
hose expected to be observed in animals consuming diets contain-
ng non-GM maize grain (MacKenzie et al., 2007).
Because the test substance administered in feeding studies with
oods from GM crops are complex mixtures it is not possible to
dminister multiple doses that are orders of magnitude in excess
f the next closest dose. Furthermore, in the case where the food
rom the GM crop was obtained from soybeans or maize grain,
hese substances are already signiﬁcant components of the grain-
ased diets which laboratory animals are usually fed. What is im-ortant to note from the feeding studies conducted with foods
rom GM crops is that they have been conducted for comparative
urposes. In other words, they are conducted with foods from GM
rops that presumably have been demonstrated to be composition-
lly equivalent using analytical methods and that they express pro-
eins that are not allergenic or toxic using methods described ear-
ier in this chapter.
Of the published 90 day feeding studies that have been con-
ucted with GM maize grain (Hammond et al., 1996, 2004, 2006a,
006b; Dryzga et al., 2007; MacKenzie et al., 2007; Malley et al.,
007; Healy et al., 2008; Appenzeller et al., 2009a, 2009b; He
t al., 2009; Liu et al., 2012; Delaney et al., 2013; Zhu et al.,
013), processed soybean fractions (Appenzeller et al., 2008; De-
aney et al., 2008a; Chukwudebe et al., 2012; Qi et al., 2012), rice
Song et al., 2014), and canola (Delaney et al., 2014) and no ev-
dence of adverse effects have been observed. Additional studies
ave been conducted to assess the effects of longer term dietary
xposure to foods from GM crops and others to assess the effects
n reproductive and developmental effects and again no evidence
f adverse effects was observed (Brake and Evenson, 2004).
In addition to these studies, numerous feeding studies have
een conducted in livestock species. The most frequently con-
ucted study is the 6 week feeding study conducted in broiler
hickens. This species was selected for evaluating the nutritional
uality of foods, or more speciﬁcally maize grain and processed
oybean fractions, for two reasons. First, the broiler chicken is very
ensitive to nutritional imbalances in the diet. Over the interval of
6 week feeding interval, these animals grow from approximately
0 g to nearly 2 kg. Second, the early generation GM crops were
oybeans and corn which compose a large fraction of the diets
ormally consumed by broiler chickens. In fact, maize grain and
oybean meal combined can constitute nearly 90% of the diet con-
umed by broiler chickens. Much of the maize grain and soybean
eal that is produced annually is speciﬁcally intended for com-
ercial livestock feeding.
These poultry would be classiﬁed nutritional performance or
omparison studies rather than safety studies as they compare
ariables including body weight, weight gain, and carcass traits
etween animals consuming diets that contained whole grains or
rocessed fractions from GM and non-GM crops. A large number
f broiler feeding studies indicate no evidence of nutritional infe-
iority has been observed for whole foods from GM crops (Taylor
t al., 2004, 2007; McNaughton et al., 2007a, 2007b, 2008a, 2008b,
011a, 2011b, 2014; Herman et al., 2011).
Many feeding studies with whole foods from GM crops have
lso been conducted in other livestock species including lay-
ng hens, swine, dairy and beef cattle, and a number of other
pecies as well (http://www.fass.org/page.asp?pageID=52&autotry=
rue&ULnotkn=true). While historically these studies have not in-
luded as many in-life variables as were assessed in the rat studies,
hey were based on commercial practice. It would not be accurate
o characterize them as safety studies but more in support of nutri-
ional comparison. As with laboratory rats and broiler chickens, no
vidence of adverse effects has been observed in these studies in
nimals consuming whole foods and processed feed fractions from
M crops.
In ﬁnding no evidence of adverse effects these feeding studies
upport the substantial equivalence of foods from GM crops.
. Countries with developing economies
Though the beneﬁts and safety of biotechnology have been well
ocumented they have typically been developed by large, multi-
ational companies and required signiﬁcant resources and time.
ountries with developing economies certainly stand to beneﬁt
rom crops developed with biotechnology whether importing grain





























































nor seeds from foreign countries or developing their own GM crops.
However, access to the same resources may not be available in
countries with developing economies.
There are several scenarios that apply to consideration of
the safety of foods from GM crops as related to countries with
developing economies that will be discussed in the ﬁnal section of
this chapter. The ﬁrst is considering importation of foods from GM
crops that were developed in another country. The second relates
to import of seeds from GM crops developed in other countries
for cultivation. Third is the consideration of safety assessment
for products developed within country. Finally, the possibility of
exportation of foods or seeds from GM crops developed within
country.
Regardless of the possible scenario to consider, the assessment
of safety should be based on demonstrating that the foods from
any particular GM crop are as safe as the appropriate comparator
from non-GM crops.
5.1. Import of foods from GM crops
The methods discussed above demonstrate how the safety of
foods from GM crops has been assessed primarily for GM maize
and soybeans that express insecticidal or herbicide tolerance pro-
teins. When considering the import of maize grain or soybeans
from GM crops into countries with developing economies it would
be expected that high quality data generated to demonstrate the
safety of any individual GM crop would be suitable regardless of
the country in which it is submitted. This is referred to as data
transportability – the application of data produced in one geo-
graphic location to support the safety assessment of that same
product in another.
Regulators, scientists, and to whatever extent possible the pub-
lic at large, in countries with developing economies should expect
the same level of conﬁdence about the safety of imported foods
from GM crops. The methodology described in the prior sections
emphasizes the universality of the data to demonstrate that when
produced in accordance with the appropriate guidelines. Safety
data for proteins expressed in GM crops and from composition and
feeding studies conducted with foods from GM crops is suitable to
support the safety assessment regardless of the geography toward
which it is applied. From the scientiﬁc perspective, it is not nec-
essary to reproduce safety assessment data in countries with de-
veloping economies to improve the conﬁdence in the safety of GM
crops though it is likely that some regulatory agencies will require
repetition of some studies.
5.2. Importation of seeds for cultivation of GM crops
The primary factor that differentiates importation of foods from
seeds is environmental exposure. For example, many countries im-
port soybeans from the US for use in animal feed. Because nearly
all of the soybeans grown in the US are GM, it is very likely
that the imported soybeans will therefore be GM. However, they
will not be imported for cultivation as the safety assessment for
cultivation would almost certainly necessitate a consideration for
environmental impact. Recommendations and guidelines for these
types of assessments are available but will not be discussed here
as they fall outside of the scope of this chapter (US EPA, 1998b
and 2001; Garcia-Alonso et al., 2006; Raybould, 2006; Rose, 2007;
Romeis et al., 2008, 2011; Carstens et al., 2012, 2014).
5.3. In country development
Recognizing the beneﬁts of biotechnology, countries with devel-
oping economies are also produce GM crops for domestic use. Its also anticipated that these nascent GM crops will include agri-
ulturally beneﬁcial traits such as insect resistance and herbicide
olerance which was shy those traits were extensively discussed
n this chapter. It is also anticipated that these crops will include
any foods intended for human consumption like papaya, squash,
omato, pepper and potatoes rather than soybeans and maize grain
much of which is used as animal feed. In fact, it has been esti-
ated that as much as 90% of the GM crop biomass is currently
sed as livestock feed (Van Eenennaam and Young, 2014). What
s important to remember is that the safety assessment processes
nd the tools that have been developed to assess the safety of soy-
eans and maize from GM crops apply regardless of the plant.
It is possible and perhaps even likely that GM crops produced
n countries with developing economies will be modiﬁed to ex-
ress proteins that have already been evaluated for safety (i.e., al-
ergenicity and toxicity). In this case, there is also likely to be sig-
iﬁcant relevant data for those proteins that should be considered.
ost importantly, if such data are available then the developers
ould not need to reproduce the data but rather to simply access
t and possibly update bioinformatics comparisons if necessary.
In the case where novel proteins are being considered, safety
ata and new studies will be required. Some of the information
n these assessments can be obtained with minimal resources and
raining and should be considered very early in the development
rocess. For example, the source of the particular protein and
hether that source is known to produce allergenic or proteins can
e done largely by analysis of published literature. Bioinformatics
omparison tools are also readily available but will require some
mount of training for the user.
In vitro digestion studies with puriﬁed proteins are the ﬁrst
oint in the discussion of this topic where the data require-
ents would necessitate signiﬁcant resources. Though the diges-
ion assays themselves are reproducible and can be conducted in-
xpensively using commonly available laboratory equipment and
eagents, it is the production and characterization of the protein it-
elf that could present a signiﬁcant barrier in countries with devel-
ping economies. The amounts of proteins typically used in these
ssays are relatively small (several milligrams) and the resources
ecessary to isolate them may not be an issue, what does become
n issue is their characterization. Testing guidelines and recom-
endations state that the proteins used in these studies should
e biochemically equivalent to those expressed in planta in GM
rops. However, in most instances, the proteins are expressed in
lanta at very low concentrations so it is not practical to isolate
he quantity of protein necessary to conduct these studies from
he plants in which they are expressed. Accordingly, heterologous
xpression systems have been utilized to express and isolate the
roteins that are used in digestibility studies and in studies to be
iscussed later in this chapter. The isolation of proteins from het-
rologous expression systems can be diﬃcult and time consuming
nd in some cases such as with transmembrane proteins may not
ven be possible (Bushey et al., 2014).
What may prove to be more challenging in countries with de-
eloping economies is the analytical instrumentation often nec-
ssary to establish “identity” of the proteins when expressed in
lanta and in vitro. Biochemical equivalence includes laboratory
ata about the purity of the protein in the preparation but often
lso includes comparison of the size and immunoreactivity, pep-
ide mapping, N-terminal sequencing, glycosylation, and biological
ctivity may be necessary.
Additional challenges will be encountered when and if acute
nd repeated dose toxicology studies are to be conducted. In the
ase of proteins that have already been evaluated for safety and
his information already exists, again, there is no obvious need to
eproduce it. If these types of studies are to be conducted with
ovel proteins then it will likely be necessary to isolate and char-
























































































































tcterize multiple gram quantities of pure protein which can be
xtremely time consuming and resource intensive. To date, of the
roteins used in GM crops that have been evaluated for acute and
epeated dose toxicity, no evidence of adverse effects have been
bserved. This supports the concept that the information necessary
o evaluate protein safety can be obtained without these types of
tudies (Delaney et al., 2007) however, regulatory agencies may re-
uire them.
Composition analysis of whole foods from GM crops should be
onsidered as a component of the safety testing. As noted above,
he identities and concentration ranges of key components from a
umber of ﬁeld crops (maize, soybeans, canola, rice and cotton) is
ublicly available and maintained (https://www.cropcomposition.
rg/query/index.html). If a newly developed GM crop is among
hese products then that information is available then access to
hat type of information will be very helpful establishing substan-
ial equivalence. What will also need to be considered is the design
f the ﬁeld studies to produce the substances that will be evalu-
ted compositionally.
If the new GM crop is not among these (and many will not be)
r for which historical composition data is available then estab-
ishing substantial equivalence may prove more challenging. Com-
osition data may need to be considered on a food-by-food basis is
hich components to test and the normal range of their concentra-
ions in non-GM plants. It may be necessary to obtain detailed in-
ormation about the individual components of the food from non-
M crops obtained over the course of multiple growing seasons.
n the absence of this information, statistical comparisons of the
oncentrations of individual components are likely to be diﬃcult
o interpret.
Finally, there is the issue of animal feeding studies using whole
oods from GM crops. Early recommendations for the safety assess-
ent of whole foods from GM crops stated that they should be
onsidered if indicated from consideration of other data as they
ould help to support substantial equivalence for individual GM
rops. Over the past nearly 20 years many such studies have been
ompleted in rats, broiler chickens, and other livestock species as
oted earlier in this chapter. In none of these cases was there any
vidence of treatment related adverse effects. From these observa-
ions it could be concluded that feeding studies with whole foods
rom GM crops should not necessarily be required for every new
roduct.
Nevertheless, if for whatever reason, it is determined that a
eeding study is to be conducted with a whole food from a GM
rop in a country with a developing economy, there is much to
e learned from the studies that have been conducted. The studies
onducted to date have focused on comparative assessment of the
ood from the GM crop with a corresponding control from an ap-
ropriate, closely related, non-GM crop. In these types of studies,
he test substance should be incorporated into the diet at a sig-
iﬁcant proportion of the diet, fed to the animals for a reasonably
ong period of time and statistical comparisons should be made
or predetermined variables that are relevant to assess the overall
ealth and nutritional performance of the diets.
Studies with processed soybean fractions and maize grain from
M crops have consistently demonstrated the importance of ad-
itional control data. Should these types of studies be conducted,
omparison of a large number of variables between a GM and non-
M control group will be expected to identify statistical differences
etween them. However, the purpose of conducting these studies
s not to identify statistical differences, but to identify treatment-
elated adverse effects. As discussed above, previous studies have
isely included additional “reference” groups that consumed di-
ts containing the same concentration of whole foods from unre-
ated, non-GM, commercially available crops to assist in establish-
ng within-study ranges for individual variables that was necessaryo interpret the data from the studies. Similarly, data from histori-
al control animals has also been useful in interpretation of the re-
ults from these types of studies when statistical differences were
bserved between animals consuming whole foods from GM and
on-GM crops. The data from reference control groups and his-
orical control groups has aided in determining whether statistical
ifferences between the primary control and experimental groups
imply do not automatically serve to identify an adverse effect.
With regard to conducting animal feeding studies with whole
oods from GM crops in countries with developing economies for
he purposes of safety assessment, the ﬁrst consideration should
e whether or not they should be conducted. They are resource
ntensive and prone to misinterpretation if not properly controlled
r conducted in a laboratory that does not have an established his-
ory of conducting these types of studies. Should an animal feeding
tudy be conducted, it will be critical that it be properly controlled
ith a predesigned protocol in a quality laboratory with the facili-
ies necessary to interpret the results. In some cases, animal feed-
ng studies have been conducted in the country in which they were
eveloped. In situations like this there is either little or nothing to
ain from repeating them in other locations.
. Conclusions
It has been estimated that hunger affects an estimated 1 bil-
ion people many of whom live in countries with developing
conomies. Population growth and decreased availability of arable
and will continue to confound this issue. Modern biotechnology
as the potential to be a signiﬁcant tool in ﬁghting hunger as it
as been well established to address agricultural problems such
ield loss from insect infestation, completion with weeds, and even
rought.
Biotechnology has been used to improve the quality and yield
f ﬁeld crops in many parts of the world for more than 20 years.
t is more speciﬁc and relatively fast in development compared
ith traditional breeding techniques. A comprehensive safety as-
essment has been conducted on GM crops before the products
re commercialized that includes evaluation of proteins used in
hese crops for potential allergenicity and toxicity as well as anal-
sis of the composition of the crop and often feeding studies in
odents and livestock species in support of demonstrating substan-
ial equivalence. The studies to do so have required signiﬁcant re-
ources, equipment and training and to date they have collectively
emonstrated that biotechnology as a tool in agriculture is not in-
erently hazardous as no evidence of adverse effects has been ob-
erved.
These learnings apply to countries with developing economies
or various reasons. To begin, they highlight the methods that have
een used to assess the safety of foods from GM crops for more
han 20 years. The methods have proven very effective and the
oncepts will readily apply to ﬁeld crops regardless of the geog-
aphy in which they are developed. Regulators and scientists in
ountries with developing economies have the opportunity to ben-
ﬁt from these ﬁndings with regard to the methods so that they
an consider the safety studies submitted from outside their coun-
ry for the purposes of import and possibly for cultivation (i.e.,
ortability). These learning can also serve to minimize or eliminate
ithin country study repeat of laboratory studies that is unnec-
ssary and consumes resources that could be better applied else-
here.
Countries in which GM crops have been developed have bene-
ted from agricultural biotechnology and countries with develop-
ng economies will also beneﬁt from application of this technol-
gy. The standards followed for safety assessment of foods from
M crops are comprehensive and have proven very effective. Coun-
ries with developing economies will also beneﬁt from key learn-





















Eings with early generation GM crops and applying them to a differ-
ent range of ﬁeld crops for products developed in their own coun-
tries.
Presuming that countries with developing economies will have
less access to funding and technical resources they will need to de-
termine if that alone will prevent them from developing GM crops.
Alternatively, that key learnings be taken from the GM products
currently on the market and determine what will be necessary
to develop them on their own. The lack of resources should not
negatively impact the beneﬁcial effects and improved qualities of
GM plants and the standards for safety should not be any different
than in more developed countries.
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